Literature DB >> 2656687

The primary structure of the core protein of the small, leucine-rich proteoglycan (PG I) from bovine articular cartilage.

P J Neame1, H U Choi, L C Rosenberg.   

Abstract

Two forms of small, interstitial proteoglycans have been isolated from bovine articular cartilage and have different core proteins, based on NH2-terminal analysis and peptide mapping (Choi, H. U., Johnson, T. L., Pal, S., Tang, L-H., Rosenberg, L. C., and Neame, P. J. (1989) J. Biol. Chem. 264, 2876-2884). These proteoglycans have been called PG I and PG II. Since they were first described, they have also been called "biglycan" (PG I), "decorin," and "DS-PG" (PG II). This report describes the primary structure of PG I from bovine articular cartilage. The protein core consists of 331 amino acids with a molecular mass of 37,280 Da. The amino acid sequence shows 55% identity to the cDNA-derived sequence of PG II from bovine bone. There are four discrete domains in the amino acid sequence. Domain 1, at the NH2 terminus (approximately 23 amino acids), contains two sites of attachment of dermatan sulfate, both of which match the consensus sequence of Asp/Glu-X-X-Ser-Gly-hydrophobic. Neither of these sites is substituted to 100% with glycosaminoglycan in native PG I. Domain 2, near the NH2 terminus and containing approximately 28 amino acids, has a cysteine pattern similar to a domain near the COOH terminus of mouse metallothionein and contains at least one disulfide bond (between the first and fourth cysteine residues). The majority of the core protein of PG I (domain 3) is a leucine-rich domain containing ten repeating units (approximately 231 amino acids). Patthy [1987) J. Mol. Biol. 198, 567-577) has shown that for PG II, the majority of domain 3 shows considerable similarity to leucine-rich alpha 2-glycoprotein (LRG) from serum. Domain 2 of PG I or PG II also has an analog in LRG, in that it has two cysteines in a similar place. The major motif in the PG I described here, in PG II and in LRG, is a series of leucine-rich repeats. PG I and PG II both contain 10 leucine-rich repeats which are 14 amino acids long and which are somewhat irregularly spaced, while LRG contains 9 leucine-rich repeats spaced 10 amino acids apart. Other proteins which contain leucine repeats are the platelet glycoprotein Ib, which is involved in platelet adherence to subendothelium (eight repeats in the alpha chain and two in the beta chain), the protein encoded by the Toll gene (involved in lateral and ventral spatial organization in Drosophila) and chaoptin (a protein involved in Drosophila photoreceptor morphogenesis).(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2656687

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

1.  Proteoglycans synthesized by an osteoblast-like cell line (UMR 106-01).

Authors:  D J McQuillan; D M Findlay; A M Hocking; M Yanagishita; R J Midura; V C Hascall
Journal:  Biochem J       Date:  1991-07-01       Impact factor: 3.857

2.  Identification of heterogeneous cell populations in normal human intervertebral disc.

Authors:  M K Chelberg; G M Banks; D F Geiger; T R Oegema
Journal:  J Anat       Date:  1995-02       Impact factor: 2.610

3.  Ribosome-binding protein p34 is a member of the leucine-rich-repeat-protein superfamily.

Authors:  T Ohsumi; T Ichimura; H Sugano; S Omata; T Isobe; R Kuwano
Journal:  Biochem J       Date:  1993-09-01       Impact factor: 3.857

4.  Non-proteoglycan forms of biglycan increase with age in human articular cartilage.

Authors:  P J Roughley; R J White; M C Magny; J Liu; R H Pearce; J S Mort
Journal:  Biochem J       Date:  1993-10-15       Impact factor: 3.857

5.  Defective glycosylation of decorin and biglycan, altered collagen structure, and abnormal phenotype of the skin fibroblasts of an Ehlers-Danlos syndrome patient carrying the novel Arg270Cys substitution in galactosyltransferase I (beta4GalT-7).

Authors:  Daniela G Seidler; Muhammad Faiyaz-Ul-Haque; Uwe Hansen; George W Yip; Syed H E Zaidi; Ahmad S Teebi; Ludwig Kiesel; Martin Götte
Journal:  J Mol Med (Berl)       Date:  2006-04-01       Impact factor: 4.599

6.  Immunohistochemical localization of articular cartilage proteoglycan and link protein in situ using monoclonal antibodies and lectin-binding methods.

Authors:  S Hoedt-Schmidt; J McClure; M K Jasani; D A Kalbhen
Journal:  Histochemistry       Date:  1993-05

7.  Proteoglycans and catabolic products of proteoglycans present in ligament.

Authors:  Mirna Z Ilic; Phillip Carter; Alicia Tyndall; Jayesh Dudhia; Christopher J Handley
Journal:  Biochem J       Date:  2005-01-15       Impact factor: 3.857

8.  Binding characteristics of the osteoarthritis-associated protein asporin.

Authors:  Ikuyo Kou; Masahiro Nakajima; Shiro Ikegawa
Journal:  J Bone Miner Metab       Date:  2010-01-07       Impact factor: 2.626

9.  Presence of pro-forms of decorin and biglycan in human articular cartilage.

Authors:  P J Roughley; R J White; J S Mort
Journal:  Biochem J       Date:  1996-09-15       Impact factor: 3.857

10.  Occurrence of PG-Lb, a leucine-rich small chondroitin/dermatan sulphate proteoglycan in mammalian epiphyseal cartilage: molecular cloning and sequence analysis of the mouse cDNA.

Authors:  K Kurita; T Shinomura; M Ujita; M Zako; D Kida; H Iwata; K Kimata
Journal:  Biochem J       Date:  1996-09-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.